Reversing DOAC Bleeding: How has the management of life-threatening bleeds changed?

 
Loading

Reversing DOAC Bleeding: How has the management of life-threatening bleeds changed?

09 Nov 2021
AGM Theatre 2

Join Dr. Amir Jehangir to discuss the key role of acute and emergency medics in reversing FXa inhibitor-related life-threatening or uncontrolled bleeds. An overview of the products currently being used to reverse bleeds will be discussed alongside a summary of the ANNEXA-4 clinical trial and an example of the multidisciplinary team involved in adding a new reversal agent to a hospital formulary. The practical implications of administering such a product will also be explained

Speakers
Amir Jehangir, Consultant in Acute and General Medicine - University College Hospital London
GOLD SPONSOR

GOLD SPONSOR

  

GOLD SPONSOR

  • A. Menarini Farmaceutica Internazionale Srl

 

GOLD SPONSOR

  • Alexion Pharma

 

GOLD SPONSOR

  • BMS-Pfizer

 

GOLD SPONSOR

  • FUJIFILM SONOSITE

 

GOLD SPONSOR

SD

SILVER SPONSOR

  • Boston Scientific

 

SILVER SPONSOR

  • Bial Pharma

 

SILVER SPONSOR

  • The MDU

 

SILVER SPONSOR

  • MDDUS

 

SILVER SPONSOR

GF

SILVER SPONSOR

JK

SILVER SPONSOR

SILVER SPONSOR

  

Lanyard Sponsor

Lanyard Sponsor

      

Lanyard Sponsor

Lanyard Sponsor

      

Don't miss your chance to get involved